Back to LYEL
Almitas Capital LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
4
Latest value
$4.4M
Q3 2026
Peak value
$17.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $17.8M |
| Q1 2026 | $11.6M |
| Q2 2026 | $8.2M |
| Q3 2026 | $4.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.4M | 448.1K | — | — |
| Q2 2026 | $8.2M | 581.4K | — | — |
| Q1 2026 | $11.6M | 577.8K | — | — |
| Q4 2025 | $17.8M | 577.8K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M
Other Almitas Capital LLC positions
FBTC
$117.1MFIDELITY WISE ORIGIN BITCOIN
FBTC
$90.7MFIDELITY WISE ORIGIN BITCOIN
FBTC
$78.7MFIDELITY WISE ORIGIN BITCOIN
FBTC
$69.7MFIDELITY WISE ORIGIN BITCOIN
ASA
$42MASA GOLD AND PRECIOUS MTLS L
BSTZ
$33.9MBLACKROCK MUN TARGET TERM TR
BSTZ
$33.8MBLACKROCK MUN TARGET TERM TR
BSTZ
$33.7MBLACKROCK MUN TARGET TERM TR